| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0146-2806(97)80014-X |
| P698 | PubMed publication ID | 9039495 |
| P2093 | author name string | Scheinman MM | |
| Barron HV | |||
| Viskin S | |||
| Olgin JE | |||
| Heller K | |||
| P2860 | cites work | Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities | Q72885801 |
| Radiofrequency ablation of atrial flutter. Efficacy of an anatomically guided approach | Q72893550 | ||
| Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease | Q72906519 | ||
| Hazards of postoperative atrial arrhythmias | Q72939296 | ||
| The effects of acetylcholine in the heart‐lung preparation including the production of auricular fibrillation | Q78732553 | ||
| Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response | Q93632895 | ||
| Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial | Q28300531 | ||
| Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone | Q28317165 | ||
| Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators | Q28318466 | ||
| A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation | Q28318589 | ||
| Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide | Q28329701 | ||
| Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide | Q28333258 | ||
| Atrial flutter in patients treated for atrial fibrillation with propafenone | Q28336014 | ||
| Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol | Q28340406 | ||
| Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation | Q28340885 | ||
| Atrial fibrillation as an independent risk factor for stroke: the Framingham Study | Q29614200 | ||
| Predictors of acute and long-term success after radiofrequency catheter ablation of type 1 atrial flutter | Q30464587 | ||
| Propafenone in Wolff-Parkinson-White syndrome at risk | Q33159118 | ||
| Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation | Q33610619 | ||
| Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin | Q33610685 | ||
| Electrophysiology and pharmacology of cardiac arrhythmias. IV. Cardiac antiarrhythmic and toxic effects of digitalis | Q33972497 | ||
| Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators | Q33978001 | ||
| Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome | Q34061216 | ||
| Alcohol and new onset atrial fibrillation: a case-control study of a current series | Q34118207 | ||
| The natural history of lone atrial fibrillation. A population-based study over three decades | Q34186025 | ||
| Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study | Q34201000 | ||
| Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting | Q34242357 | ||
| Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion | Q34272548 | ||
| Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome | Q34327153 | ||
| Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity | Q34345947 | ||
| Beta blockade during and after myocardial infarction: an overview of the randomized trials | Q34557544 | ||
| Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats | Q34721297 | ||
| Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study | Q34734292 | ||
| Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials | Q35269994 | ||
| Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter | Q35902898 | ||
| Thyrotoxicosis and the heart | Q36200940 | ||
| Electrical cardioversion for persistent atrial fibrillation after treatment of thyrotoxicosis | Q36717584 | ||
| Response of atrial flutter to overdrive atrial pacing and intravenous disopyramide phosphate, singly and in combination | Q36774881 | ||
| Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size | Q36776934 | ||
| Characterization of atrioventricular nodal behavior and ventricular response during atrial fibrillation before and after a selective slow-pathway ablation. | Q51610679 | ||
| Effect of magnesium sulfate on ventricular rate control in atrial fibrillation. | Q51630336 | ||
| Titration of intravenous anesthetics for cardioversion: a comparison of propofol, methohexital, and midazolam. | Q51653355 | ||
| The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation. | Q51672046 | ||
| Midazolam sedation reversed with flumazenil for cardioversion. | Q51695655 | ||
| Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting. | Q51706074 | ||
| Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. | Q52342463 | ||
| Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. | Q52884209 | ||
| Long-term follow-up of patients treated by radiofrequency ablation of the atrioventricular junction. | Q53639508 | ||
| Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. | Q54087868 | ||
| Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. | Q54114563 | ||
| Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study. | Q54126951 | ||
| Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: report of three cases. | Q54196432 | ||
| Oral flecainide for prophylaxis of paroxysmal atrial fibrillation. | Q54378382 | ||
| Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. | Q54513498 | ||
| Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. | Q55054117 | ||
| Selective radiofrequency ablation of the "slow" atrioventricular nodal pathway for control of the ventricular response to atrial fibrillation | Q57221671 | ||
| Probability of stroke: a risk profile from the Framingham Study | Q57746223 | ||
| Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension | Q58819310 | ||
| The Role of Catheter Ablation Techniques in the Treatment of Classic (Type 1) Atrial Flutter | Q61650798 | ||
| Efficacy of intravenous propafenone for the acute management of atrial fibrillation | Q61704179 | ||
| Beta-blocker therapy in the cardiac arrhythmia suppression trial | Q61819914 | ||
| Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter | Q61965280 | ||
| Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter | Q61965304 | ||
| Optimal technique for electrical cardioversion of atrial fibrillation | Q67483753 | ||
| Catheter ablation of the atrioventricular junction using radiofrequency energy and a bilateral cardiac approach | Q67586247 | ||
| Arterial embolism in thyrotoxicosis with atrial fibrillation | Q67673971 | ||
| Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators | Q67716321 | ||
| Effects of Amiodarone on Serum T3and T4Concentrations in Hyperthyroid Patients Treated with Propylthiouracil | Q67908767 | ||
| Stroke Prevention in Atrial Fibrillation Study. Final results | Q67925848 | ||
| Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias | Q67986525 | ||
| Reversible protective effect of propafenone or flecainide during atrial fibrillation in patients with an accessory atrioventricular connection | Q68051039 | ||
| Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group | Q68058122 | ||
| High success rate of atrioventricular node ablation with radiofrequency energy | Q68071786 | ||
| Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up | Q68079912 | ||
| Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry) | Q68092325 | ||
| Management of atrial fibrillation | Q68092512 | ||
| A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation | Q68145281 | ||
| Amiodarone in the management of refractory atrial fibrillation | Q68186769 | ||
| Sinus node-atrioventricular node isolation: long-term results with the "corridor" operation for atrial fibrillation | Q68206900 | ||
| Stroke in thyrotoxicosis with atrial fibrillation | Q68252913 | ||
| The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm | Q68368848 | ||
| Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortality | Q68444637 | ||
| Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm | Q68461404 | ||
| Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm | Q68495464 | ||
| Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation | Q68498046 | ||
| Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation | Q68516428 | ||
| Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs | Q68709077 | ||
| Randomized placebo-controlled trial of propafenone for treatment of atrial tachyarrhythmias after cardiac surgery | Q68831188 | ||
| Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm | Q68899284 | ||
| A comparison of verapamil and digoxin in the treatment of atrial fibrillation | Q68950319 | ||
| Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium | Q69258719 | ||
| Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter | Q69368479 | ||
| Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation | Q69461347 | ||
| Usefulness of propafenone for recurrent paroxysmal atrial fibrillation | Q69491616 | ||
| Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval | Q69566742 | ||
| Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group | Q69876883 | ||
| Diltiazem, verapamil, and quinidine in patients with chronic atrial fibrillation | Q69892830 | ||
| Long-term results of the corridor operation for atrial fibrillation | Q36812138 | ||
| Electrical reversion of cardiac arrhythmias | Q36930296 | ||
| Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective | Q38516208 | ||
| Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group | Q39278247 | ||
| Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter | Q39478696 | ||
| The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis | Q39523454 | ||
| Summary of efficacy and safety of flecainide for supraventricular arrhythmias | Q39604703 | ||
| QT dispersion: problems of methodology and clinical significance. | Q40558761 | ||
| Is there any indication for an intracardiac defibrillator for the treatment of atrial fibrillation? | Q40612202 | ||
| Pacemaker therapy in patients with atrial fibrillation | Q40708407 | ||
| Results of radiofrequency catheter ablation for atrial flutter | Q40995262 | ||
| Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association | Q41000819 | ||
| Catheter ablation of atrial flutter using radiofrequency energy | Q41042529 | ||
| To fumble flutter or tackle "tach"? Toward updated classifiers for atrial tachyarrhythmias | Q41044718 | ||
| Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy | Q41179390 | ||
| Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution | Q41674224 | ||
| Survival after recovery from acute myocardial infarction. Two and five year prognostic indices | Q41718897 | ||
| Recurrent atrial arrhythmias following treatment for postoperative atrial fibrillation after coronary bypass operations | Q41865872 | ||
| Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy | Q42214611 | ||
| Sustained atrial fibrillation after conversion of paroxysmal reciprocating junctional tachycardia by intravenous verapamil | Q42215143 | ||
| Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care | Q42221096 | ||
| Ventricular fibrillation following verapamil in the Wolff-Parkinson-White syndrome | Q42260182 | ||
| Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group | Q42281464 | ||
| Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure | Q42282724 | ||
| Comparative effects of the combination of digoxin and dl-sotalol therapy versus digoxin monotherapy for control of ventricular response in chronic atrial fibrillation. dl-Sotalol Atrial Fibrillation Study Group | Q42284869 | ||
| Verapamil-induced atrial fibrillation | Q42661619 | ||
| Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation | Q43419712 | ||
| Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group | Q43443801 | ||
| Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil | Q43453208 | ||
| Clinical efficacy of flecainide acetate in atrial fibrillation | Q43753675 | ||
| Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators | Q43764537 | ||
| Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques | Q43828093 | ||
| Canadian atrial fibrillation anticoaguiation (CAFA) study | Q43928649 | ||
| Quinidine treatment of chronic lone atrial fibrillation | Q43939220 | ||
| Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial | Q43969736 | ||
| A randomized comparison of external and internal cardioversion of chronic atrial fibrillation | Q44028202 | ||
| The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation | Q44153210 | ||
| Entrainment and interruption of atrial flutter with atrial pacing: studies in man following open heart surgery | Q44198532 | ||
| A Comparison of Intravenous Propafenone and Flecainide in the Treatment of Tachycardias Associated with the Wolff-Parkinson-White Syndrome | Q44234611 | ||
| Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation | Q44284914 | ||
| Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset | Q44526252 | ||
| Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia | Q45038588 | ||
| Predictors of in-hospital mortality after DC catheter ablation of atrioventricular junction. Results of a prospective, international, multicenter study. | Q45940756 | ||
| Percutaneous radiofrequency catheter ablation for supraventricular arrhythmias in children. | Q45950022 | ||
| Role of right atrial endocardial structures as barriers to conduction during human type I atrial flutter. Activation and entrainment mapping guided by intracardiac echocardiography | Q46084332 | ||
| Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation | Q46248979 | ||
| Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction | Q46265465 | ||
| Magnesium therapy in new-onset atrial fibrillation | Q46486271 | ||
| Predictors of major vascular events in patients with a transient ischemic attack or minor ischemic stroke and with nonrheumatic atrial fibrillation. European Atrial Fibrillation Trial (EAFT) Study Group | Q49226979 | ||
| Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm. | Q50750535 | ||
| Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. | Q51591676 | ||
| Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. | Q51604516 | ||
| Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin | Q72589995 | ||
| Low-energy endocardial defibrillation using an axillary or a pectoral thoracic electrode location | Q72636833 | ||
| Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation | Q72655008 | ||
| Long-term Prevention of Vagal Atrial Arrhythmias by Atrial Pacing at 90/Minute: Experience with 6 Cases | Q72703031 | ||
| Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications | Q72740780 | ||
| A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators | Q72833441 | ||
| ??? | Q28341602 | ||
| Risk of stroke in non-rheumatic atrial fibrillation | Q69894816 | ||
| Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation | Q69901331 | ||
| Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double-blind clinical trial | Q69916325 | ||
| Amiodarone for refractory atrial fibrillation | Q69992187 | ||
| Hypotension after quinidine plus verapamil. Possible additive competition at alpha-adrenergic receptors | Q70077345 | ||
| The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation | Q70105143 | ||
| Failure of long-term digitalization to prevent rapid ventricular response in patients with paroxysmal atrial fibrillation | Q70127967 | ||
| Efficacy of disopyramide in conversion and prophylaxis of post-thyrotoxic atrial fibrillation | Q70212941 | ||
| Epidemiologic features of chronic atrial fibrillation: the Framingham study | Q70294399 | ||
| Management of atrial fibrillation in the post-thyrotoxic state | Q70388688 | ||
| Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens | Q70400484 | ||
| Comparison of flecainide and procainamide in cardioversion of atrial fibrillation | Q70493406 | ||
| Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation | Q70573988 | ||
| Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter | Q70595096 | ||
| Impaired subsidiary pacemaker function in patients with a right bundle branch block created prior to complete catheter ablation of the AV junction | Q70658915 | ||
| Arterial embolism in thyrotoxicosis with atrial fibrillation | Q70862982 | ||
| Electrophysiological effects of catheter ablation of inferior vena cava-tricuspid annulus isthmus in common atrial flutter | Q70866665 | ||
| Controlled trial of a long-acting quinidine for maintenance of sinus rhythm after conversion of sustained atrial fibrillation | Q70906358 | ||
| Efficacy of amiodarone for refractory supraventricular tachyarrhythmias | Q71019706 | ||
| Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study | Q71020117 | ||
| Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation | Q71634799 | ||
| Clinical course of acute atrial fibrillation treated with rapid digitalization | Q71657363 | ||
| Efficacy of ajmaline and propafenone in patients with accessory pathways: a prospective randomized study | Q71665860 | ||
| Closed-chest ablation of the atrioventricular conduction system | Q71707792 | ||
| Antithrombotic therapy in atrial fibrillation | Q71732669 | ||
| Adverse acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar cardiac pacing systems | Q71742036 | ||
| Efficacy of i.v. amiodarone in converting rapid atrial fibrillation and flutter to sinus rhythm in intensive care patients | Q71762924 | ||
| The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model | Q71782637 | ||
| Radiofrequency catheter ablation of atrial flutter: Procedural success and long-term outcome | Q71877884 | ||
| The Risk of Atrial Fibrillation Following Radiofrequency Catheter Ablation of Atrial Flutter | Q71955992 | ||
| Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results | Q71964521 | ||
| Radiofrequency catheter ablation of type 1 atrial flutter. Prediction of late success by electrophysiological criteria | Q72034085 | ||
| Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study | Q72051686 | ||
| Recovery of atrial function after atrial compartment operation for chronic atrial fibrillation in mitral valve disease | Q72069077 | ||
| ICD versus Drugs in Cardiac Arrest Survivors: Preliminary Results of the Cardiac Arrest Study Hamburg | Q72075833 | ||
| Successful Catheter Ablation of Atrial Fibrillation | Q72111586 | ||
| Radiofrequency catheter ablation of common atrial flutter in 80 patients | Q72168598 | ||
| Short- and long-term prognostic implications of in-hospital postinfarction arrhythmias. DAVIT II Study Group | Q72187253 | ||
| The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study | Q72198409 | ||
| Risk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables | Q72248423 | ||
| Modulation of atrioventricular conduction by ablation of the "slow" atrioventricular node pathway in patients with drug-refractory atrial fibrillation or flutter | Q72352921 | ||
| Characterization of junctional rhythm after atrioventricular node ablation | Q72369081 | ||
| Clinical course of recent-onset atrial fibrillation treated with oral propafenone | Q72374285 | ||
| Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study | Q72523256 | ||
| Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation | Q72526986 | ||
| Beta-blocking therapy in atrial and ventricular tachyarrhythmias: experience with nadolol | Q72589987 | ||
| P433 | issue | 2 | |
| P921 | main subject | Atrial Fibrillation | Q815819 |
| P304 | page(s) | 37-108 | |
| P577 | publication date | 1997-02-01 | |
| P1433 | published in | Current Problems in Cardiology | Q2153546 |
| P1476 | title | The treatment of atrial fibrillation: pharmacologic and nonpharmacologic strategies | |
| P478 | volume | 22 |
| Q44147865 | Cardioversion of atrial fibrillation with ibutilide: when is it most effective? |
| Q33642495 | Current status of calcium channel blockers in patients with cardiovascular disease |
| Q34422572 | Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry |
| Q35110930 | Long QT syndrome caused by noncardiac drugs |
| Q33145098 | Long QT syndromes and torsade de pointes |
| Q33597990 | Management of intermittent atrial fibrillation: drugs to maintain sinus rhythm |
| Q37554693 | New pharmacological strategies for the treatment of atrial fibrillation |
| Q34074578 | Prevention of ventricular arrhythmias in the congenital long QT syndrome |
| Q28081709 | Rate Control Strategy Elevated To Primary Treatment For Atrial Fibrillation: Has The Last Word Already Been Spoken? |
| Q45711404 | The efficacy of scheduled cardioversion in atrial fibrillation. Comparison of two schemes of treatment: electrical versus pharmacological cardioversion |
| Q77468071 | Unexpected instant death following successful coronary artery bypass graft surgery (and other clinical settings): atrial fibrillation, quinidine, procainamide, et cetera, and instant death |
| Q84033276 | [Severe bacterial infection: increased mortality in elderly women with low body weight taking drugs prolonging the QTc interval] |
Search more.